Results: Patients treated with FPF 1070 demonstrated statistically significant (p < 0.05 or p < 0.01) improvements in MMSE, SCAG and NAI scores and in the ZVT test at the end-point of treatment ...
WHEATON, Ill., February 20, 2025--First Trust Intermediate Duration Preferred & Income Fund (the "Fund") (NYSE: FPF) has declared the Fund’s regularly scheduled monthly common share distribution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback